Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer
Treadwell Therapeutics, a clinical-stage, global biotechnology company developing novel, first-in-class therapeutics for highly aggressive cancers, […]
Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
Personalis, a leader in advanced genomics for precision oncology, and Moderna, a biotechnology company pioneering […]
RefleXion Receives FDA Clearance for Biology-Guided Radiotherapy Treatment for Early and Late-stage Cancers
RefleXion Medical, a therapeutic oncology company, today announced the US Food and Drug Administration (FDA) […]
Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer
Cardiff Oncology, a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to […]
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-MMP7 for Treatment of Idiopathic Pulmonary Fibrosis
Arrowhead Pharmaceuticals announced today that it has dosed the first subjects in a Phase 1/2a […]
Agomab Reports Positive Phase 1 Results with AGMB-129, a GI-restricted ALK5 Inhibitor for Fibrostenosing Crohn’s Disease
Agomab Therapeutics today announced positive clinical results from its Phase 1 study evaluating AGMB-129, an […]
The World Health Organisation chooses British air purification company, MedicAir, to tackle ‘invisible threat’ in hospitals
British air purification company, MedicAir, has beaten international firms to be awarded a year-long contract by […]
Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC)
Genoscience Pharma, a clinical-stage biotech company developing unique lysosomotropic drug candidates for the treatment of […]
Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid Leukaemia
Ellipses Pharma, a global drug development company focused on accelerating the development of cancer medicines […]
NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition
The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more